文档介绍:深圳市血液核酸检测工作情况汇报
NAT与ELISA检测的配合
先做血清学检测再做核酸检测
血样经常规血清学检测(ELISA)二遍,均呈非反应性,
取EIA呈非反应性的标本多人份(或)血样,混合进行核酸检测。
感染,例被证实为隐匿性感染,例Chiron试剂反应性/ROCH试剂非反应性,为不确定标本。
另有份标本尚未开始后续检测。
当前我国输血安全形势严峻、为保证血液安全,预防输血性感染的发生有条件的采供血机构应尽快考虑在血液筛查中增加NAT技术。
深圳血液中心核酸检测情况
虽然NAT在血液筛查应用中降低了输血传播病毒感染的残余风险,但和存在一定问题和不足。
、NAT不能完全替代血清学筛查(EIA+/NAT-)
、存在一定的检测错误率
、NAT的成本效益分析
标本号
ELISA-进口
(S/CO)
ELISA-国产
(S/CO)
NAT-Ultrio实验(S/CO)
NAT鉴别实验(S/CO)
-/.
-/.
+/.
+/.
-/.
-/.
+/.
+/.
-/.
-/.
+/.
+/.
-/.
-/.
+/.
+/.
-/.
-/.
+/.
+/.
ELISA非反应性、NAT检测HBV-DNA阳性结果
样品编号
EIA-进口
S/CO
EIA-国产
S/CO
NAT-Ultrio
S/CO
NAT-鉴别
S/CO
+/.
-/.
+/.
-/.
+/.
-/.
+/.
+/.
+/.
-/.
-
-
-/.
+/.
-
-
+/.
-/.
+/.
+/.
+/.
-/.
-
-
+/.
-/.
-
-
-/.
+/.
-
-
+/.
-/.
-
-
+/.
-/.
-
-
+/.
-/.
-
-
+/.
-/.
-
-
-/.
+/.
-
-
+/.
-/.
-
-
-/.
+/.
-
-
-/.
-/.
-
-
-/.
+/.
-
-
-/.
+/.
-
-
HBsAg-ELISA检测单试剂呈反应性,NAT检测情况一览表
样品编号
EIA-进口
S/CO
EIA-国产
S/CO
NAT-Ultrio
S/CO
NAT-鉴别
S/CO
+/.
+/.
+/.
+/.
+/.
+/.
+/.
+/.
+/.
+/.
-
-
+/.
+/.
+/.
+/.
+/.
+/.
+/.
+/.
+/.
+/.
+/.
+/.
+/.
+/.
+/.
-/.
+/.
+/.
+/.
没做
+/.
+/.
+/.
+/.
+/.
+/.
+/.
+/.
+/.
+/.
+/.
+/.
+/.
+/.
+/.
+/.
+/.
+/